. home.aspx


Authorized Generics Explained

August 13, 2019

DRUGMAKERS LATEST GAMBIT EXPLAINED: DESIGNED TO EXTEND MARKET EXCLUSIVITY AND STIFLE OR DELAY COMPETITION, AUTHORIZED GENERICS CAN BE MORE PROFITABLE THAN BRAND. In 1984, the Hatch-Waxman Act established the modern generic drug business by establishing rules for safety and competition, including granting six months of market exclusivity to the first generic rival to each brand. Big Pharma found a way to circumvent that.